375 related articles for article (PubMed ID: 29799851)
1. Prevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease.
Hughes J; Y Y Chiu D; Kalra PA; Green D
PLoS One; 2018; 13(5):e0197400. PubMed ID: 29799851
[TBL] [Abstract][Full Text] [Related]
2. Systematic review: hypomagnesaemia induced by proton pump inhibition.
Hess MW; Hoenderop JG; Bindels RJ; Drenth JP
Aliment Pharmacol Ther; 2012 Sep; 36(5):405-13. PubMed ID: 22762246
[TBL] [Abstract][Full Text] [Related]
3. [Severe hypomagnesaemia due to proton pump inhibitor use].
van den Berg S; Scheer MLJ; Holman ND
Ned Tijdschr Geneeskd; 2018 Aug; 162():. PubMed ID: 30182626
[TBL] [Abstract][Full Text] [Related]
4. Proton pump inhibitor associated hypomagnasaemia - a cause for concern?
Begley J; Smith T; Barnett K; Strike P; Azim A; Spake C; Richardson T
Br J Clin Pharmacol; 2016 Apr; 81(4):753-8. PubMed ID: 26613375
[TBL] [Abstract][Full Text] [Related]
5. Inulin significantly improves serum magnesium levels in proton pump inhibitor-induced hypomagnesaemia.
Hess MW; de Baaij JH; Broekman M; Bisseling TM; Haarhuis B; Tan A; Te Morsche R; Hoenderop JG; Bindels RJ; Drenth JP
Aliment Pharmacol Ther; 2016 Jun; 43(11):1178-85. PubMed ID: 27086738
[TBL] [Abstract][Full Text] [Related]
6. Proton pump inhibitor use and progression to major adverse renal events: a competing risk analysis.
Grant CH; Gillis KA; Lees JS; Traynor JP; Mark PB; Stevens KI
QJM; 2019 Nov; 112(11):835-840. PubMed ID: 31251364
[TBL] [Abstract][Full Text] [Related]
7. Low Prevalence of Hypomagnesemia in Long-term Recipients of Proton Pump Inhibitors in a Managed Care Cohort.
Sharara AI; Chalhoub JM; Hammoud N; Harb AH; Sarkis FS; Hamadeh G
Clin Gastroenterol Hepatol; 2016 Feb; 14(2):317-21. PubMed ID: 26499924
[TBL] [Abstract][Full Text] [Related]
8. Proton pump inhibitors not associated with hypomagnesemia, regardless of dose or concomitant diuretic use.
Chowdhry M; Shah K; Kemper S; Zekan D; Carter W; McJunkin B
J Gastroenterol Hepatol; 2018 Oct; 33(10):1717-1721. PubMed ID: 29514412
[TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitor use for 12 months is not associated with changes in serum magnesium levels: a prospective open label comparative study.
Bahtiri E; Islami H; Hoxha R; Gashi A; Thaçi K; Karakulak Ç; Thaçi S; Qorraj Bytyqi H
Turk J Gastroenterol; 2017 Mar; 28(2):104-109. PubMed ID: 28082254
[TBL] [Abstract][Full Text] [Related]
10. The association of proton pump inhibitors and hypomagnesemia in the community setting.
Markovits N; Loebstein R; Halkin H; Bialik M; Landes-Westerman J; Lomnicky J; Kurnik D
J Clin Pharmacol; 2014 Aug; 54(8):889-95. PubMed ID: 24771616
[TBL] [Abstract][Full Text] [Related]
11. Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study.
Kieboom BC; Kiefte-de Jong JC; Eijgelsheim M; Franco OH; Kuipers EJ; Hofman A; Zietse R; Stricker BH; Hoorn EJ
Am J Kidney Dis; 2015 Nov; 66(5):775-82. PubMed ID: 26123862
[TBL] [Abstract][Full Text] [Related]
12. Severe hypomagnesaemia in long-term users of proton-pump inhibitors.
Cundy T; Dissanayake A
Clin Endocrinol (Oxf); 2008 Aug; 69(2):338-41. PubMed ID: 18221401
[TBL] [Abstract][Full Text] [Related]
13. The Association between the Use of Proton Pump Inhibitors and the Risk of Hypomagnesemia in a National Cohort of Veteran Patients with HIV.
Sutton SS; Magagnoli J; Cummings T; Hardin JW
J Int Assoc Provid AIDS Care; 2019; 18():2325958218821652. PubMed ID: 30798693
[TBL] [Abstract][Full Text] [Related]
14. Proton pump inhibitor-associated hypomagnesemia: what do FDA data tell us?
Luk CP; Parsons R; Lee YP; Hughes JD
Ann Pharmacother; 2013 Jun; 47(6):773-80. PubMed ID: 23632281
[TBL] [Abstract][Full Text] [Related]
15. [An unknown but potentially serious side effect of proton pump inhibitors: hypomagnesaemia].
Doornebal J; Bijlsma R; Brouwer RM
Ned Tijdschr Geneeskd; 2009; 153():A711. PubMed ID: 19930736
[TBL] [Abstract][Full Text] [Related]
16. Proton-Pump Inhibitors and Hypomagnesaemia in Kidney Transplant Recipients.
Douwes RM; Gomes-Neto AW; Schutten JC; van den Berg E; de Borst MH; Berger SP; Touw DJ; Hak E; Blokzijl H; Navis G; Bakker SJL
J Clin Med; 2019 Dec; 8(12):. PubMed ID: 31817776
[TBL] [Abstract][Full Text] [Related]
17. Severe symptomatic hypomagnesaemia induced by the chronic use of proton pump inhibitors: a case report of a patient with Zollinger-Ellison syndrome.
Ströker E; Leone L; Vandeput Y; Borbath I; Lefebvre C
Acta Clin Belg; 2014; 69(1):62-5. PubMed ID: 24635401
[TBL] [Abstract][Full Text] [Related]
18. Thiazide but not loop diuretics is associated with hypomagnesaemia in the general population.
Kieboom BCT; Zietse R; Ikram MA; Hoorn EJ; Stricker BH
Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1166-1173. PubMed ID: 30095199
[TBL] [Abstract][Full Text] [Related]
19. Short-term proton pump inhibitor treatment may cause hypomagnesaemia in critically ill patients - a pilot study.
Krzych ŁJ; Łój P; Nowak T; Kazura W; Knapik P
Acta Biochim Pol; 2017; 64(3):499-501. PubMed ID: 28651024
[TBL] [Abstract][Full Text] [Related]
20. Impact of proton pump inhibitor use on magnesium homoeostasis: a cross-sectional study in a tertiary emergency department.
Lindner G; Funk GC; Leichtle AB; Fiedler GM; Schwarz C; Eleftheriadis T; Pasch A; Mohaupt MG; Exadaktylos AK; Arampatzis S
Int J Clin Pract; 2014 Nov; 68(11):1352-7. PubMed ID: 24898571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
